[Hepatocellular carcinoma recurrence in PEI site--a case report].
The patient was 63-year-old male. Abdominal CT revealed a tumor at S2/S3, which led to a diagnosis of hepatocellular carcinoma, in April 1998. On April 15, 1998 transcathetereal arterial embolization was performed and on May 11, 1998 percutaneous ethanol injection therapy was given, but a viable lesion remained. On July 2, 1998, partial resection of S2/S3 was performed. There was an intrahepapic metastatic lesion at Glisson's site of the main tumor, which was suspected of implantation. In December 2000, the patient had a high AFP level, and a recurrent tumor was observed at S3 on abdominal CT. In June 2001, S3 subsegmentectomy was performed, because the recurrent tumor existed in the Glisson S3 area.
Ota
Hideo
H
Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.
Nagano
Hiroaki
H
Sakon
Masato
M
Inoue
Tsuyoshi
T
Hayashi
Shoho
S
Kondo
Motoi
M
Arai
Isao
I
Morimoto
Osakuni
O
Yamamoto
Tameyoshi
T
Nakamura
Masato
M
Dono
Keizo
K
Umeshita
Koji
K
Nakamori
Shoji
S
Wakasa
Kenichi
K
Monden
Morito
M
D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009366:Neoplasm Seeding
D000431:Ethanol